Driving Digital Innovation in Life Sciences

Q1. Could you start by giving us a brief overview of your professional journey, particularly your experience leading digital transformation and enterprise architecture initiatives across healthcare and life sciences?

Technology executive with over 30+ years of experience in enterprise architecture, product engineering, and digital transformation within the Healthcare and Life Sciences domain. Have worked with leading global Pharma and Medical devices companies, helping them define IT strategy and roadmap, evaluate technologies, design and implement digital transformation initiatives, modernize legacy systems, and drive innovation with emerging technologies such as Cloud, Agentic AI, GenAI, AI/ML, IoT, and IoMT.

Q2. Digital transformation in healthcare and life sciences often faces challenges moving beyond proofs of concept. Based on your experience, what are the key architectural and organisational enablers for scaling innovation sustainably across global enterprises?

Yes, many digital transformation initiatives often fail to move beyond the proof-of-concept stage, primarily when there is no real business benefit or ROI. A lot of times, companies try to adopt emerging technology without evaluating the real ROI, which is when these initiatives fail. While technology can help with many things, it should translate into real, tangible business benefits, such as improving customer satisfaction, operational efficiency, and the top…